LAB Logo

Standard BioTools Inc. (LAB) 

NASDAQ$1.14
Market Cap
$432.04M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
19 of 924
Rank in Industry
1 of 49

LAB Insider Trading Activity

LAB Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$22,977,16423100
Sells
$000

Related Transactions

Casdin Partners Master Fund, L.P.23$22.98M0$0$22.98M

About Standard BioTools Inc.

Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical â€¦

Insider Activity of Standard BioTools Inc.

Over the last 12 months, insiders at Standard BioTools Inc. have bought $22.98M and sold $0 worth of Standard BioTools Inc. stock.

On average, over the past 5 years, insiders at Standard BioTools Inc. have bought $13.45M and sold $514,009 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Casdin Partners Master Fund, L.P. () — $22.98M.

The last purchase of 4,820,959 shares for transaction amount of $5.13M was made by Casdin Partners Master Fund, L.P. () on 2025‑02‑28.

List of Insider Buy and Sell Transactions, Standard BioTools Inc.

2025-02-28PurchaseCasdin Partners Master Fund, L.P.
4.82M
1.2482%
$1.06$5.13M+7.08%
2024-08-27PurchaseCasdin Partners Master Fund, L.P.
250,000
0.0798%
$2.19$546,750-16.51%
2024-08-26PurchaseCasdin Partners Master Fund, L.P.
150,000
0.0471%
$2.15$322,455-16.13%
2024-08-23PurchaseCasdin Partners Master Fund, L.P.
292,100
0.0907%
$2.13$620,975-14.95%
2024-08-22PurchaseCasdin Partners Master Fund, L.P.
307,900
0.088%
$1.96$602,807-6.67%
2024-08-21PurchaseCasdin Partners Master Fund, L.P.
500,000
0.139%
$1.90$951,950-5.93%
2024-08-20PurchaseCasdin Partners Master Fund, L.P.
500,000
0.1368%
$1.87$936,700-1.61%
2024-08-19PurchaseCasdin Partners Master Fund, L.P.
250,000
0.0676%
$1.85$463,225-4.19%
2024-08-14PurchaseCasdin Partners Master Fund, L.P.
1.2M
0.2794%
$1.59$1.91M+18.06%
2024-08-13PurchaseCasdin Partners Master Fund, L.P.
550,000
0.13%
$1.62$890,560+11.96%
2024-08-12PurchaseCasdin Partners Master Fund, L.P.
500,000
0.1198%
$1.64$820,600+14.47%
2024-08-09PurchaseCasdin Partners Master Fund, L.P.
525,408
0.1239%
$1.61$848,481+12.35%
2024-08-08PurchaseCasdin Partners Master Fund, L.P.
569,562
0.1362%
$1.64$932,601+8.98%
2024-08-07PurchaseCasdin Partners Master Fund, L.P.
500,000
0.1148%
$1.57$786,200+15.19%
2024-08-05PurchaseCasdin Partners Master Fund, L.P.
200,000
0.0462%
$1.58$316,780+14.47%
2024-08-02PurchaseCasdin Partners Master Fund, L.P.
1M
0.2382%
$1.63$1.63M+10.30%
2024-05-23PurchaseCasdin Partners Master Fund, L.P.
100,000
0.038%
$2.60$260,000-29.12%
2024-05-22PurchaseCasdin Partners Master Fund, L.P.
150,000
0.0566%
$2.58$387,735-28.57%
2024-05-21PurchaseCasdin Partners Master Fund, L.P.
350,000
0.1308%
$2.56$895,930-28.29%
2024-05-20PurchaseCasdin Partners Master Fund, L.P.
100,000
0.0377%
$2.58$258,130-28.10%
Total: 428
*Gray background shows transactions not older than one year

Insider Historical Profitability

15.57%
Casdin Partners Master Fund, L.P.
58846780
15.5274%
$67.09M280<0.0001%
Caligan Partners LP10 percent owner
11444836
3.0199%
$13.05M180<0.0001%
JOHNSON DAVID EDWARD
11189663
2.9525%
$12.76M80<0.0001%
LEVIN CAPITAL STRATEGIES, L.P.10 percent owner
10473809
2.7636%
$11.94M1110+23.89%
TORRAY ROBERT Edirector
2381164
0.6283%
$2.71M40
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

Standard BioTools Inc.
(LAB)
$53,318,456
175
15.57%
$432.04M
$38,597,637
114
658.88%
$2.47M
$1,590,764
16
3.90%
$55.22M
$26,663,659
7
-12.13%
$20.04B
$151,252
6
-58.10%
$11.58M

LAB Institutional Investors: Active Positions

Increased Positions63+39.38%14M+4.93%
Decreased Positions61-38.13%17M-5.94%
New Positions22New6MNew
Sold Out Positions21Sold Out1MSold Out
Total Postitions162+1.25%277M-1.02%

LAB Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Casdin Capital, Llc$75,886.0019.15%71.25M00%2024-12-31
Viking Global Investors Lp$62,463.0015.77%58.65M00%2024-12-31
Blackrock, Inc.$26,474.006.68%24.86M+2M+10.71%2024-12-31
Vanguard Group Inc$18,271.004.61%17.16M-135,946-0.79%2024-12-31
Morgan Stanley$17,946.004.53%16.85M+2M+10.53%2024-12-31
Millennium Management Llc$7,542.001.9%7.08M+97,479+1.4%2024-12-31
Geode Capital Management, Llc$7,429.001.88%6.98M+25,504+0.37%2024-12-31
Sumitomo Mitsui Trust Group, Inc.$7,049.001.78%6.62M-3M-30.9%2024-12-31
Nikko Asset Management Americas, Inc.$7,049.001.78%6.62M-3M-30.86%2024-12-31
Tikvah Management Llc$6,977.001.76%6.55M00%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.